Copyright: ©Author(s) 2026.
World J Clin Cases. Sep 16, 2026; 14(26): 126744
Published online Sep 16, 2026. doi: 10.12998/wjcc.126744
Published online Sep 16, 2026. doi: 10.12998/wjcc.126744
Table 3 Etiologic evaluation of acute liver failure and limitations of retrospective causality assessment
| Etiologic category | Investigation or exposure | Available result/documentation | Interpretation or limitation |
| Viral hepatitis | Viral hepatitis investigation | Documented as negative in the medical record | The contemporaneous medical record documented negative viral hepatitis testing; individual viral assays, numerical results, methods, and testing dates were unavailable for independent retrospective verification |
| Autoimmune liver disease | Autoimmune liver-disease investigation | Documented as negative in the medical record | The medical record documented a negative autoimmune liver-disease investigation; individual autoantibodies, immunoglobulin results, methods, and testing dates were unavailable for independent retrospective verification |
| Wilson disease | Wilson disease evaluation | Documented as investigated and excluded | Wilson disease was documented as investigated and excluded; the individual diagnostic tests, numerical results, methods, and dates were unavailable for independent retrospective verification |
| Hemochromatosis | Hemochromatosis evaluation | Documented as investigated and excluded | Hemochromatosis was documented as investigated and excluded; the individual diagnostic tests, numerical results, methods, and dates were unavailable for independent retrospective verification |
| Additional viral testing | HEV, HSV, EBV, and CMV testing | Documented as investigated/negative in the medical record | The original individual assay results, methods, and testing dates were unavailable for independent retrospective verification |
| Drug or toxin exposure | Acetaminophen, alcohol, illicit/recreational drugs, and other medications or supplements | Patient denied acetaminophen use, alcohol consumption, and illicit/recreational drug use; no additional medications or supplements were reported beyond omeprazole and P. major infusion | No competing exposure was identified from the documented history other than omeprazole. A serum acetaminophen concentration and formal toxicology screening results were not available for retrospective verification |
| Competing medication | Omeprazole | Documented exposure | The exact dose and exposure dates were unavailable; omeprazole was retained as a competing exposure |
| Herbal exposure | P. major infusion | Approximately 2 L/day for 15 consecutive days | This represents prepared infusion volume only. Botanical authentication, quantified botanical dose, chemical analysis, and contamination testing were not available |
| Rechallenge | Re-exposure to P. major | Not performed | No rechallenge occurred |
| Dechallenge | Biochemical course after cessation | Not interpretable | Liver transplantation occurred before biochemical recovery, preventing interpretation of a conventional dechallenge course |
- Citation: Ponte RV, Faria AA, Guedes LR, Yamashiro IS, Macedo ML, Lima MC, Souza PF, Vidigal PV, Penna FG, Sancio JB. Acute liver failure temporally associated with intensive consumption of Plantago major tea: A case report. World J Clin Cases 2026; 14(26): 126744
- URL: https://www.wjgnet.com/2307-8960/full/v14/i26/126744.htm
- DOI: https://dx.doi.org/10.12998/wjcc.126744